Blog

AstraZeneca to pay up to $2 billion to license cardiovascular drug

7 de outubro de 2024 by

in News

AstraZeneca on Monday said it will pay up to $2 billion to license a cardiovascular drug.

Relacionado

Leave a Reply Cancel reply

Ads Blocker Detected!!!

We have detected that you are using extensions to block ads. Please support us by disabling these ads blocker.

Ads Blocker Detected!!!

We have detected that you are using extensions to block ads. Please support us by disabling these ads blocker.

Refresh

100% Free SEO Tools - Tool Kits PRO